Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Kavanagh

Showing results (111-120 of 154) with videos related to

Pageof 16
Sort By:
Clinical Sarcoma Research|July 16, 2015
Perioperative chemotherapy in the treatment of osteosarcoma: a 26-year single institution reviewG M O'Kane, K A Cadoo, E M Walsh, et al.
Comprehensive Psychiatry|July 31, 2020
Personality disorder increases risk of low quality of life among women with mental state disordersBianca E Kavanagh, Amanda L Stuart, Michael Berk, et al.
Chest|September 4, 2020
Real-World Effectiveness of Benralizumab in Severe Eosinophilic AsthmaJoanne E Kavanagh, Andrew P Hearn, Jaideep Dhariwal, et al.
Cancer Letters|November 1, 2015
Impact of the inflammatory microenvironment on T-cell phenotype in the progression from reflux oesophagitis to Barrett oesophagus and oesophageal adenocarcinomaMaria E Kavanagh, Melissa J Conroy, Niamh E Clarke, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 23, 2020
Adjunctive <i>Garcinia mangostana</i> Linn. (Mangosteen) Pericarp for Schizophrenia: A 24-Week Double-blind, Randomized, Placebo Controlled Efficacy Trial: Péricarpe d'appoint Garcinia mangostana Linn (mangoustan) pour la schizophrénie : un essai d'efficacité de 24 semaines, à double insu, randomisé et contrôlé par placeboAlyna Turner, Andrea Baker, Olivia M Dean, et al.
BMJ Open|March 22, 2020
Minocycline for the treatment of mental health and neurological conditions: study protocol of a systematic review and meta-analysisChiara C Bortolasci, Wolfgang Marx, Adam J Walker, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|March 26, 2019
Protocol and Rationale: A 24-week Double-blind, Randomized, Placebo Controlled Trial of the Efficacy of Adjunctive <i>Garcinia mangostana</i>Linn. (Mangosteen) Pericarp for SchizophreniaAlyna Turner, John J McGrath, Olivia M Dean, et al.
Schizophrenia Bulletin|January 1, 1982
Assessment of brain function in clinical pediatric research: behavioral and biological strategiesJ G Young, D J Cohen, S E Shaywitz, et al.
Journal of Affective Disorders|November 16, 2020
Systematic review and meta-analysis of the role of personality disorder in randomised controlled trials of pharmacological interventions for adults with mood disordersBianca E Kavanagh, Melanie M Ashton, Stephanie P Cowdery, et al.
BMC Medicine|May 20, 2025
The portfolio dietary pattern and risk of cardiovascular disease mortality during 1988-2019 in US adults: a prospective cohort studyMeaghan E Kavanagh, Andreea Zurbau, Andrea J Glenn, et al.
Pageof 16

Showing results (111-120 of 154) with videos related to

Sort By:
Pageof 16
Clinical Sarcoma Research|July 16, 2015
Perioperative chemotherapy in the treatment of osteosarcoma: a 26-year single institution reviewG M O'Kane, K A Cadoo, E M Walsh, et al.
Comprehensive Psychiatry|July 31, 2020
Personality disorder increases risk of low quality of life among women with mental state disordersBianca E Kavanagh, Amanda L Stuart, Michael Berk, et al.
Chest|September 4, 2020
Real-World Effectiveness of Benralizumab in Severe Eosinophilic AsthmaJoanne E Kavanagh, Andrew P Hearn, Jaideep Dhariwal, et al.
Cancer Letters|November 1, 2015
Impact of the inflammatory microenvironment on T-cell phenotype in the progression from reflux oesophagitis to Barrett oesophagus and oesophageal adenocarcinomaMaria E Kavanagh, Melissa J Conroy, Niamh E Clarke, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 23, 2020
Adjunctive <i>Garcinia mangostana</i> Linn. (Mangosteen) Pericarp for Schizophrenia: A 24-Week Double-blind, Randomized, Placebo Controlled Efficacy Trial: Péricarpe d'appoint Garcinia mangostana Linn (mangoustan) pour la schizophrénie : un essai d'efficacité de 24 semaines, à double insu, randomisé et contrôlé par placeboAlyna Turner, Andrea Baker, Olivia M Dean, et al.
BMJ Open|March 22, 2020
Minocycline for the treatment of mental health and neurological conditions: study protocol of a systematic review and meta-analysisChiara C Bortolasci, Wolfgang Marx, Adam J Walker, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|March 26, 2019
Protocol and Rationale: A 24-week Double-blind, Randomized, Placebo Controlled Trial of the Efficacy of Adjunctive <i>Garcinia mangostana</i>Linn. (Mangosteen) Pericarp for SchizophreniaAlyna Turner, John J McGrath, Olivia M Dean, et al.
Schizophrenia Bulletin|January 1, 1982
Assessment of brain function in clinical pediatric research: behavioral and biological strategiesJ G Young, D J Cohen, S E Shaywitz, et al.
Journal of Affective Disorders|November 16, 2020
Systematic review and meta-analysis of the role of personality disorder in randomised controlled trials of pharmacological interventions for adults with mood disordersBianca E Kavanagh, Melanie M Ashton, Stephanie P Cowdery, et al.
BMC Medicine|May 20, 2025
The portfolio dietary pattern and risk of cardiovascular disease mortality during 1988-2019 in US adults: a prospective cohort studyMeaghan E Kavanagh, Andreea Zurbau, Andrea J Glenn, et al.
Pageof 16